Stocks of Gossamer Bio Inc (NASDAQ:GOSS) traded higher last session on Wall Street, up 14.34% to $0.65.
GOSS stock price is now -4.81% away from the 50-day moving average and -24.66% away from the 200-day moving average. The market capitalization of the company currently stands at $147.04M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On July 27, 2023, UBS Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $8 to quote $1.25, while ‘Raymond James’ rates the stock as ‘Mkt Perform’
In other news, Giraudo Bryan, COO/CFO bought 100,000 shares of the company’s stock on Jun 18 ’24. The stock was bought for $59,110 at an average price of $0.59. Upon completion of the transaction, the COO/CFO now directly owns 480,010 shares in the company, valued at $0.31 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 17 ’24, Chief Commercial Officer Smith Robert Paul JR bought 25,000 shares of the business’s stock. A total of $15,050 was incurred on buying the stock at an average price of $0.60. This leaves the insider owning 25,000 shares of the company worth $16250.0. A total of 16.23% of the company’s stock is owned by insiders.
During the past 12 months, Gossamer Bio Inc has had a low of $0.45 and a high of $1.88. As of last week, the company has a debt-to-equity ratio of 7.82, a current ratio of 7.13, and a quick ratio of 7.13. The fifty day moving average price for GOSS is $0.67592 and a two-hundred day moving average price translates $0.860905 for the stock.
The latest earnings results from Gossamer Bio Inc (NASDAQ: GOSS) was released for 2024-03-31. The company reported revenue of $41.96 million for the quarter, compared to $47.94 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -12.48 percent.
